EGR3 (Early Growth Response 3) is a transcription factor that regulates diverse cellular processes through sequence-specific DNA binding and transcriptional control. EGR3 functions as a mechanosensitive transcriptional regulator, responding to biomechanical forces during cardiac valve morphogenesis in zebrafish, where it acts cell-autonomously in endothelial cells and regulates downstream effectors like Nr4a2b 1. The protein plays crucial roles in immune regulation, where EGR3 deficiency leads to lupus-like autoimmune disease with dysregulated T cell activation, and it normally confers suppressive activity to CD4+ T cells while regulating inhibitory cytokines IL-10 and TGF-β1 2. In macrophages, EGR3 expression is rapidly controlled by RNA polymerase II pause/release mechanisms during efferocytosis, regulating genes involved in cytoskeleton and corpse processing 3. EGR3 also contributes to disease pathogenesis, promoting atherosclerosis development by modulating CRP and VCAM-1 expression 4, and facilitating tamoxifen resistance in breast cancer through direct transcriptional activation of the anti-apoptotic gene MCL1 5. Additionally, EGR3 is involved in melanoma cell state transitions as part of intermediate state gene regulatory networks 6 and IgE-mediated allergic responses in basophils 7.